- Home
- HSTM vs NNNN Comparison
HSTM vs NNNN Comparison
Compare HSTM & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- NNNN
- Stock Information
- Founded
- HSTM 1990
- NNNN 2021
- Country
- HSTM United States
- NNNN Germany
- Employees
- HSTM N/A
- NNNN N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HSTM Technology
- NNNN Health Care
- Exchange
- HSTM Nasdaq
- NNNN Nasdaq
- Market Cap
- HSTM 960.2M
- NNNN 267.7M
- IPO Year
- HSTM 2000
- NNNN 2025
- Fundamental
- Price
- HSTM $27.23
- NNNN $6.63
- Analyst Decision
- HSTM Hold
- NNNN
- Analyst Count
- HSTM 2
- NNNN 0
- Target Price
- HSTM $30.00
- NNNN N/A
- AVG Volume (30 Days)
- HSTM 174.2K
- NNNN 32.8K
- Earning Date
- HSTM 05-05-2025
- NNNN 01-01-0001
- Dividend Yield
- HSTM 0.45%
- NNNN N/A
- EPS Growth
- HSTM 32.31
- NNNN N/A
- EPS
- HSTM 0.66
- NNNN 0.06
- Revenue
- HSTM $291,646,000.00
- NNNN $8,185,146.00
- Revenue This Year
- HSTM $6.54
- NNNN N/A
- Revenue Next Year
- HSTM $5.26
- NNNN N/A
- P/E Ratio
- HSTM $40.82
- NNNN $116.38
- Revenue Growth
- HSTM 4.51
- NNNN 21.95
- 52 Week Low
- HSTM $25.91
- NNNN $5.18
- 52 Week High
- HSTM $34.24
- NNNN $7.82
- Technical
- Relative Strength Index (RSI)
- HSTM 28.38
- NNNN N/A
- Support Level
- HSTM $25.84
- NNNN N/A
- Resistance Level
- HSTM $34.13
- NNNN N/A
- Average True Range (ATR)
- HSTM 0.92
- NNNN 0.00
- MACD
- HSTM -0.71
- NNNN 0.00
- Stochastic Oscillator
- HSTM 16.77
- NNNN 0.00
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.